{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:37:05Z","timestamp":1761863825718,"version":"3.41.2"},"reference-count":53,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T00:00:00Z","timestamp":1523836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"crossref","award":["R15GM126503"],"award-info":[{"award-number":["R15GM126503"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007828","name":"Kansas Bioscience Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007828","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007828","name":"Kansas Bioscience Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007828","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Appl Environ Microbiol"],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            To assess phenotypic bacterial antimicrobial resistance (AMR) in different strata (e.g., host populations, environmental areas, manure, or sewage effluents) for epidemiological purposes, isolates of target bacteria can be obtained from a stratum using various sample types. Also, different sample processing methods can be applied. The MIC of each target antimicrobial drug for each isolate is measured. Statistical equivalence testing of the MIC data for the isolates allows evaluation of whether different sample types or sample processing methods yield equivalent estimates of the bacterial antimicrobial susceptibility in the stratum. We demonstrate this approach on the antimicrobial susceptibility estimates for (i) nontyphoidal\n            <jats:named-content content-type=\"genus-species\">Salmonella<\/jats:named-content>\n            spp. from ground or trimmed meat versus cecal content samples of cattle in processing plants in 2013-2014 and (ii) nontyphoidal\n            <jats:named-content content-type=\"genus-species\">Salmonella<\/jats:named-content>\n            spp. from urine, fecal, and blood human samples in 2015 (U.S. National Antimicrobial Resistance Monitoring System data). We found that the sample types for cattle yielded nonequivalent susceptibility estimates for several antimicrobial drug classes and thus may gauge distinct subpopulations of salmonellae. The quinolone and fluoroquinolone susceptibility estimates for nontyphoidal salmonellae from human blood are nonequivalent to those from urine or feces, conjecturally due to the fluoroquinolone (ciprofloxacin) use to treat infections caused by nontyphoidal salmonellae. We also demonstrate statistical equivalence testing for comparing sample processing methods for fecal samples (culturing one versus multiple aliquots per sample) to assess AMR in fecal\n            <jats:named-content content-type=\"genus-species\">Escherichia coli<\/jats:named-content>\n            . These methods yield equivalent results, except for tetracyclines. Importantly, statistical equivalence testing provides the MIC difference at which the data from two sample types or sample processing methods differ statistically. Data users (e.g., microbiologists and epidemiologists) may then interpret practical relevance of the difference.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>IMPORTANCE<\/jats:bold>\n            Bacterial antimicrobial resistance (AMR) needs to be assessed in different populations or strata for the purposes of surveillance and determination of the efficacy of interventions to halt AMR dissemination. To assess phenotypic antimicrobial susceptibility, isolates of target bacteria can be obtained from a stratum using different sample types or employing different sample processing methods in the laboratory. The MIC of each target antimicrobial drug for each of the isolates is measured, yielding the MIC distribution across the isolates from each sample type or sample processing method. We describe statistical equivalence testing for the MIC data for evaluating whether two sample types or sample processing methods yield equivalent estimates of the bacterial phenotypic antimicrobial susceptibility in the stratum. This includes estimating the MIC difference at which the data from the two approaches differ statistically. Data users (e.g., microbiologists, epidemiologists, and public health professionals) can then interpret whether that present difference is practically relevant.\n          <\/jats:p>","DOI":"10.1128\/aem.02724-17","type":"journal-article","created":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T16:16:42Z","timestamp":1522253802000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":8,"title":["Establishing Statistical Equivalence of Data from Different Sampling Approaches for Assessment of Bacterial Phenotypic Antimicrobial Resistance"],"prefix":"10.1128","volume":"84","author":[{"given":"Heman","family":"Shakeri","sequence":"first","affiliation":[{"name":"Institute of Computational Comparative Medicine, Kansas State University, Manhattan, Kansas, USA"},{"name":"Department of Anatomy and Physiology, Kansas State University, Manhattan, Kansas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoriya","family":"Volkova","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Medicine\/Pathobiology, Kansas State University, Manhattan, Kansas, USA"},{"name":"Center for Outcomes Research and Epidemiology, Kansas State University, Manhattan, Kansas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuesong","family":"Wen","sequence":"additional","affiliation":[{"name":"Institute of Computational Comparative Medicine, Kansas State University, Manhattan, Kansas, USA"},{"name":"Department of Anatomy and Physiology, Kansas State University, Manhattan, Kansas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Deters","sequence":"additional","affiliation":[{"name":"Institute of Computational Comparative Medicine, Kansas State University, Manhattan, Kansas, USA"},{"name":"Department of Diagnostic Medicine\/Pathobiology, Kansas State University, Manhattan, Kansas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charley","family":"Cull","sequence":"additional","affiliation":[{"name":"Veterinary and Biomedical Research Center, Inc., Manhattan, Kansas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Drouillard","sequence":"additional","affiliation":[{"name":"Department of Animal Sciences and Industry, Kansas State University, Manhattan, Kansas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Department of Animal Sciences and Industry, Kansas State University, Manhattan, Kansas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behnaz","family":"Moradijamei","sequence":"additional","affiliation":[{"name":"Department of Statistics, Kansas State University, Manhattan, Kansas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Jaberi-Douraki","sequence":"additional","affiliation":[{"name":"Institute of Computational Comparative Medicine, Kansas State University, Manhattan, Kansas, USA"},{"name":"Department of Mathematics, Kansas State University, Manhattan, Kansas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2014.0080"},{"key":"e_1_3_2_3_2","volume-title":"Global antimicrobial resistance surveillance system: manual for early implementation","author":"WHO","year":"2015","unstructured":"WHO. 2015. Global antimicrobial resistance surveillance system: manual for early implementation, p 1\u20132. World Health Organization, Geneva, Switzerland. http:\/\/apps.who.int\/iris\/bitstream\/10665\/188783\/1\/9789241549400_eng.pdf?ua=1. Accessed 6 January 2018."},{"key":"e_1_3_2_4_2","volume-title":"CLSI document VET01-A4","author":"CLSI","year":"2013","unstructured":"CLSI. 2013. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard, 4th ed. CLSI document VET01-A4. CLSI, Wayne, PA.","edition":"4"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.2003.64.1570"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05777-11"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prevetmed.2006.01.007"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1089\/fpd.2017.2301"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/44.6.749"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/45.4.457"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.2002.63.1662"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prevetmed.2014.02.010"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00688-16"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1201\/EBK1439808184"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1037\/met0000051"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005160"},{"key":"e_1_3_2_17_2","volume-title":"Statistical procedures for bioequivalence studies","author":"FDA CDER","year":"2001","unstructured":"FDA CDER. 2001. Guidance for industry. Statistical procedures for bioequivalence studies. US Food and Drug Administration, Silver Spring, MD. https:\/\/www.fda.gov\/downloads\/drugs\/guidances\/ucm070244.pdf. Accessed 1 July 2017."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1089\/fpd.2017.2283"},{"key":"e_1_3_2_19_2","volume-title":"The National Antimicrobial Resistance Monitoring System: enteric bacteria","author":"FDA Center for Veterinary Medicine","year":"2016","unstructured":"FDA Center for Veterinary Medicine. 2016. National Antimicrobial Resistance Monitoring System (NARMS) 2014: integrated report. The National Antimicrobial Resistance Monitoring System: enteric bacteria. US Food and Drug Administration, Silver Spring, MD. https:\/\/www.fda.gov\/downloads\/AnimalVeterinary\/SafetyHealth\/AntimicrobialResistance\/NationalAntimicrobialResistanceMonitoringSystem\/UCM528861.pdf. Accessed 1 October 2017."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/9781555817435"},{"key":"e_1_3_2_21_2","volume-title":"Manual for identification and antimicrobial susceptibility testing of bacterial pathogens of public health importance in the developing world","author":"WHO","year":"2003","unstructured":"WHO. 2003. Manual for identification and antimicrobial susceptibility testing of bacterial pathogens of public health importance in the developing world. World Health Organization, Geneva, Switzerland. http:\/\/apps.who.int\/iris\/bitstream\/10665\/68554\/1\/WHO_CDS_CSR_RMD_2003.6.pdf. Accessed 1 October 2017."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178623"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.01029-06"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/genetics\/98.3.467"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.69.5.2794-2799.2003"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-765X.2004.01620.x"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prevetmed.2015.02.008"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1089\/fpd.2015.1961"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/jam.12790"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.2527\/jas.2016-0340"},{"key":"e_1_3_2_31_2","first-page":"28","article-title":"The generalisation of student's problems when several different population variances are involved","volume":"34","author":"Welch BL","year":"1947","unstructured":"Welch BL. 1947. The generalisation of student's problems when several different population variances are involved. Biometrika 34:28\u201335.","journal-title":"Biometrika"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/61.1.165"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.4315\/0362-028X.JFP-11-540"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.meatsci.2005.03.012"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.4315\/0362-028X-62.2.140"},{"key":"e_1_3_2_36_2","volume-title":"Antibiotic resistance threats in the United States","author":"Centers for Disease Control and Prevention","year":"2013","unstructured":"Centers for Disease Control and Prevention. 2013. Antibiotic resistance threats in the United States, 2013. Centers for Disease Control and Prevention, Atlanta, GA. http:\/\/www.cdc.gov\/drugresistance\/pdf\/ar-threats-2013-508.pdf. Accessed 1 February 2017."},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1086\/318457"},{"key":"e_1_3_2_38_2","first-page":"CD001167","article-title":"Antimicrobials for treating symptomatic non-typhoidal Salmonella infection","volume":"2012","author":"Onwuezobe IA","year":"2012","unstructured":"Onwuezobe IA, Oshun PO, Odigwe CC. 2012. Antimicrobials for treating symptomatic non-typhoidal Salmonella infection. Cochrane Database Syst Rev 2012:CD001167.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_39_2","volume-title":"2014 human isolates surveillance report","author":"Centers for Disease Control and Prevention National Antimicrobial Resistance Monitoring System (NARMS)","year":"2016","unstructured":"Centers for Disease Control and Prevention National Antimicrobial Resistance Monitoring System (NARMS). 2016. 2014 human isolates surveillance report. Centers for Disease Control and Prevention, Atlanta, GA. https:\/\/www.cdc.gov\/narms\/pdf\/2014-annual-report-narms-508c.pdf. Accessed 18 February 2018."},{"key":"e_1_3_2_40_2","volume-title":"National Antimicrobial Resistance Monitoring System (NARMS) 2015 integrated report","author":"FDA Center for Veterinary Medicine","year":"2017","unstructured":"FDA Center for Veterinary Medicine. 2017. National Antimicrobial Resistance Monitoring System (NARMS) 2015 integrated report. US Food and Drug Administration, Silver Spring, MD. https:\/\/www.fda.gov\/AnimalVeterinary\/SafetyHealth\/AntimicrobialResistance\/NationalAntimicrobialResistanceMonitoringSystem\/ucm059103.htm. Accessed 8 February 2018."},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/jvp.12376"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.70.4.2503-2507.2004"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01030-16"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv186"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2011.00252"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02516-15"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.femsle.2005.02.034"},{"key":"e_1_3_2_48_2","volume-title":"CLSI document M07-A10","author":"CLSI","year":"2015","unstructured":"CLSI. 2015. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 10th ed. CLSI document M07-A10. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"10"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/beheco\/ark016"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/60.2.369"},{"key":"e_1_3_2_51_2","volume-title":"A concise introduction to logic","author":"Hurley PJ","year":"2014","unstructured":"Hurley PJ. 2014. A concise introduction to logic, 12th ed. Cengage Learning, Stamford, CT.","edition":"12"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1037\/0033-2909.112.1.155"},{"key":"e_1_3_2_53_2","volume-title":"Statistical power analysis for the behavioral sciences","author":"Cohen J","year":"1988","unstructured":"Cohen J. 1988. Statistical power analysis for the behavioral sciences, 2nd ed. Lawrence Erlbaum Associates, New York, NY.","edition":"2"},{"key":"e_1_3_2_54_2","volume-title":"Manual of Laboratory Methods","author":"National Antimicrobial Resistance Monitoring System (NARMS)","year":"2016","unstructured":"National Antimicrobial Resistance Monitoring System (NARMS). 2016. Manual of Laboratory Methods, 3rd ed. US Food and Drug Administration, Silver Spring, MD. https:\/\/www.fda.gov\/downloads\/AnimalVeterinary\/SafetyHealth\/AntimicrobialResistance\/NationalAntimicrobialResistanceMonitoringSystem\/UCM528831.pdf. Accessed 1 October 2017.","edition":"3"}],"container-title":["Applied and Environmental Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AEM.02724-17","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AEM.02724-17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T18:52:00Z","timestamp":1645642320000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AEM.02724-17"}},"subtitle":[],"editor":[{"given":"Donald W.","family":"Schaffner","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.1128\/AEM.02724-17"],"URL":"https:\/\/doi.org\/10.1128\/aem.02724-17","relation":{},"ISSN":["0099-2240","1098-5336"],"issn-type":[{"type":"print","value":"0099-2240"},{"type":"electronic","value":"1098-5336"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"2017-12-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-02-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e02724-17"}}